Volker Schilling

Localization of Transforming Growth Factor-β- Expressing Cells and Comparison with Major Extracellular Components in Aural Cholesteatoma

Stephan Lang, Volker Schilling, Brigitte Mack et al. · Annals of Otology Rhinology & Laryngology · 1997 · 22 citations

Medicine, Cell Biology, Pathology +17

Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.

Andreas Dietz, Michael Flentje, Rudolf Hagen et al. · Journal of Clinical Oncology · 2014 · 12 citations

Medicine, Oncology, Surgery +15

Final results of the randomized phase II DeLOS-II trial: Induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC).

Andreas Dietz, Gunnar Wichmann, Michael Flentje et al. · Journal of Clinical Oncology · 2016 · 11 citations

Medicine, Otolaryngology, Surgery +17